THIRD EXTENSION - GRANTED
granted
on 18 Oct 2024
Last Applicant/ Owned by
3 Bioscience Park Drive
Farmingdale
NY
11735
Serial Number
97430271 filed on 26th May 2022
Registration Number
N/A
Correspondent Address
Kristen Mollnow Walsh
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
DEPYMED
Pharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cancer, rare diseases, lung disorders and respiratory diseases, cardiovascular diseases, and other metabolic, inflammatory and central nervous system or neurodegenerative diseases
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of cancer, rare diseases, lung disorders and respiratory diseases, cardiovascular diseases, and other metabolic, inflammatory and central nervous system or neurodegenerative diseases
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97430271
Mark Type
No Service Mark
Attorney Docket Number
No 74506-3
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 18th Oct 2024 | SOU EXTENSION 3 FILED |
| 18th Oct 2024 | SOU EXTENSION 3 GRANTED |
| 18th Oct 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th Oct 2024 | SOU TEAS EXTENSION RECEIVED |
| 30th Apr 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 29th Apr 2024 | SOU EXTENSION 2 GRANTED |
| 29th Apr 2024 | SOU EXTENSION 2 FILED |
| 29th Apr 2024 | SOU TEAS EXTENSION RECEIVED |
| 11th Aug 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th Aug 2023 | SOU EXTENSION 1 GRANTED |